$0.1600
al cierre: Oct 15 EDT
$0.1680
0.008005.00%
Pre-comercialización: 5:33 AM EDT
Comments
Loading...
Adaptimmune Therapeutics Informe de interés a corto plazo
ADAPNASDAQ
Informe de interés en corto
El interés corto en Adaptimmune Therapeutics PLC (NASDAQ:ADAP) ha aumentado durante el último período de informe, aumentando en aumento desde 23.05M hasta 29.65M. Esto representa el 13.55% de las acciones disponibles públicamente de la empresa.
El interés en corto en Adaptimmune Therapeutics Corp (XNAS:ADAP) disminuyó durante el último período de informe, cayendo de 280,30 millones a 275,20 millones. Esto hizo que el 1,17 % de las acciones disponibles públicamente de la empresa se pusieran en corto.
Basado en el volumen promedio reciente de 217.16M acciones negociadas por día, tomaría 1 día(s) para que los poseedores de este interés corto cierren sus posiciones sin impulsar bruscamente el precio de las acciones.
Interés en corto
29.65M
Interés en corto %
13.6%
Días para cubrir
1
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
ADAP | Adaptimmune Therapeutics plc A | 09/30/2025 | 10/09/2025 | 13.55% | 218,819,779 | 29,646,826 | 217,160,302 | 1 | |
ADAP | Adaptimmune Therapeutics plc A | 09/15/2025 | 09/24/2025 | 10.53% | 218,819,779 | 23,052,335 | 38,008,802 | 1 | |
ADAP | Adaptimmune Therapeutics plc A | 08/29/2025 | 09/10/2025 | 11.49% | 218,819,779 | 25,148,796 | 91,151,143 | 1 | |
ADAP | Adaptimmune Therapeutics plc A | 08/15/2025 | 08/26/2025 | 5.06% | 218,819,779 | 11,073,333 | 78,748,022 | 1 | |
ADAP | Adaptimmune Therapeutics plc A | 07/31/2025 | 08/11/2025 | 3.81% | 218,819,779 | 8,345,689 | 23,014,216 | 1 | |
ADAP | Adaptimmune Therapeutics plc A | 07/15/2025 | 07/24/2025 | 1.78% | 218,819,779 | 3,884,668 | 472,407 | 8.22 | |
ADAP | Adaptimmune Therapeutics plc A | 06/30/2025 | 07/10/2025 | 1.95% | 218,819,779 | 4,262,396 | 684,781 | 6.22 | |
ADAP | Adaptimmune Therapeutics plc A | 06/13/2025 | 06/25/2025 | 2.09% | 218,819,779 | 4,563,895 | 683,606 | 6.68 | |
ADAP | Adaptimmune Therapeutics plc A | 05/30/2025 | 06/10/2025 | 2.44% | 218,819,779 | 5,339,133 | 464,371 | 11.5 | |
ADAP | Adaptimmune Therapeutics plc A | 05/15/2025 | 05/27/2025 | 2.67% | 218,819,779 | 5,834,073 | 2,552,897 | 2.29 | |
ADAP | Adaptimmune Therapeutics plc A | 04/30/2025 | 05/09/2025 | 2.04% | 217,688,222 | 4,450,099 | 802,461 | 5.55 | |
ADAP | Adaptimmune Therapeutics plc A | 04/15/2025 | 04/25/2025 | 2.57% | 178,484,267 | 4,594,643 | 2,380,151 | 1.93 | |
ADAP | Adaptimmune Therapeutics plc A | 03/31/2025 | 04/09/2025 | 3.17% | 172,020,174 | 5,454,233 | 3,438,008 | 1.59 | |
ADAP | Adaptimmune Therapeutics plc A | 03/14/2025 | 03/25/2025 | 3.28% | 172,020,174 | 5,642,793 | 1,284,948 | 4.39 | |
ADAP | Adaptimmune Therapeutics plc A | 02/28/2025 | 03/11/2025 | 3.73% | 170,671,440 | 6,358,415 | 1,248,348 | 5.09 | |
ADAP | Adaptimmune Therapeutics plc A | 02/14/2025 | 02/26/2025 | 4.21% | 170,671,440 | 7,190,442 | 598,859 | 12.01 | |
ADAP | Adaptimmune Therapeutics plc A | 01/31/2025 | 02/11/2025 | 4.03% | 170,671,440 | 6,878,898 | 710,873 | 9.68 | |
ADAP | Adaptimmune Therapeutics plc A | 01/15/2025 | 01/27/2025 | 3.38% | 170,671,440 | 5,760,733 | 1,770,944 | 3.25 | |
ADAP | Adaptimmune Therapeutics plc A | 12/31/2024 | 01/10/2025 | 3.22% | 170,671,440 | 5,502,013 | 3,011,918 | 1.83 | |
ADAP | Adaptimmune Therapeutics plc A | 12/13/2024 | 12/24/2024 | 2.97% | 170,671,440 | 5,064,481 | 2,315,237 | 2.19 | |
ADAP | Adaptimmune Therapeutics plc A | 11/29/2024 | 12/10/2024 | 3.94% | 170,671,440 | 6,722,267 | 2,087,286 | 3.22 | |
ADAP | Adaptimmune Therapeutics plc A | 11/15/2024 | 11/26/2024 | 4.05% | 170,671,440 | 6,906,004 | 2,480,987 | 2.78 | |
ADAP | Adaptimmune Therapeutics plc A | 10/31/2024 | 11/11/2024 | 3.14% | 170,533,678 | 5,349,350 | 1,179,368 | 4.54 | |
ADAP | Adaptimmune Therapeutics plc A | 10/15/2024 | 10/24/2024 | 3.26% | 170,533,678 | 5,555,099 | 1,050,793 | 5.29 | |
ADAP | Adaptimmune Therapeutics plc A | 09/30/2024 | 10/09/2024 | 3.57% | 170,533,678 | 6,086,908 | 1,110,220 | 5.48 | |
ADAP | Adaptimmune Therapeutics plc A | 09/13/2024 | 09/24/2024 | 4.11% | 170,533,678 | 7,001,127 | 895,769 | 7.82 | |
ADAP | Adaptimmune Therapeutics plc A | 08/30/2024 | 09/11/2024 | 4.00% | 170,533,678 | 6,825,007 | 1,372,903 | 4.97 | |
ADAP | Adaptimmune Therapeutics plc A | 08/15/2024 | 08/26/2024 | 4.18% | 170,533,678 | 7,130,362 | 3,178,203 | 2.24 | |
ADAP | Adaptimmune Therapeutics plc A | 07/31/2024 | 08/09/2024 | 4.18% | 170,350,212 | 7,127,656 | 1,745,293 | 4.08 | |
ADAP | Adaptimmune Therapeutics plc A | 07/15/2024 | 07/24/2024 | 3.70% | 170,350,212 | 6,298,988 | 2,005,272 | 3.14 | |
ADAP | Adaptimmune Therapeutics plc A | 06/28/2024 | 07/10/2024 | 3.31% | 170,350,212 | 5,641,870 | 1,610,557 | 3.5 | |
ADAP | Adaptimmune Therapeutics plc A | 06/14/2024 | 06/26/2024 | 2.88% | 170,350,212 | 4,903,957 | 1,623,020 | 3.02 | |
ADAP | Adaptimmune Therapeutics plc A | 05/31/2024 | 06/11/2024 | 2.71% | 170,350,212 | 4,621,117 | 2,449,841 | 1.89 | |
ADAP | Adaptimmune Therapeutics plc A | 05/15/2024 | 05/24/2024 | 2.02% | 170,350,212 | 3,441,159 | 832,969 | 4.13 | |
ADAP | Adaptimmune Therapeutics plc A | 04/30/2024 | 05/09/2024 | 2.06% | 170,350,212 | 3,517,477 | 1,193,320 | 2.95 | |
ADAP | Adaptimmune Therapeutics plc A | 04/15/2024 | 04/24/2024 | 2.00% | 170,350,212 | 3,407,756 | 1,320,412 | 2.58 | |
ADAP | Adaptimmune Therapeutics plc A | 03/28/2024 | 04/09/2024 | 1.88% | 170,284,046 | 3,197,059 | 1,405,327 | 2.27 | |
ADAP | Adaptimmune Therapeutics plc A | 03/15/2024 | 03/26/2024 | 2.89% | 107,581,286 | 3,112,390 | 2,408,238 | 1.29 | |
ADAP | Adaptimmune Therapeutics plc A | 02/29/2024 | 03/11/2024 | 2.60% | 107,581,286 | 2,800,124 | 1,606,871 | 1.74 | |
ADAP | Adaptimmune Therapeutics plc A | 02/15/2024 | 02/27/2024 | 2.72% | 107,581,286 | 2,928,624 | 2,035,389 | 1.44 | |
ADAP | Adaptimmune Therapeutics plc A | 01/31/2024 | 02/09/2024 | 4.38% | 107,581,286 | 4,710,050 | 2,503,674 | 1.88 | |
ADAP | Adaptimmune Therapeutics plc A | 01/12/2024 | 01/24/2024 | 5.36% | 107,581,286 | 5,765,134 | 880,263 | 6.55 | |
ADAP | Adaptimmune Therapeutics plc A | 12/29/2023 | 01/10/2024 | 5.30% | 107,581,286 | 5,703,578 | 1,113,538 | 5.12 | |
ADAP | Adaptimmune Therapeutics plc A | 12/15/2023 | 12/27/2023 | 5.69% | 107,581,286 | 6,123,889 | 566,587 | 10.81 | |
ADAP | Adaptimmune Therapeutics plc A | 11/30/2023 | 12/11/2023 | 5.74% | 107,581,286 | 6,170,818 | 469,066 | 13.16 | |
ADAP | Adaptimmune Therapeutics plc A | 11/15/2023 | 11/27/2023 | 5.57% | 107,581,286 | 5,990,432 | 338,434 | 17.7 | |
ADAP | Adaptimmune Therapeutics plc A | 10/31/2023 | 11/09/2023 | 5.43% | 107,581,286 | 5,846,727 | 425,152 | 13.75 | |
ADAP | Adaptimmune Therapeutics plc A | 10/13/2023 | 10/24/2023 | 6.22% | 107,581,286 | 6,694,686 | 417,253 | 16.04 |
En busca de los valores más cortos?